Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

IGXBio

IGXBio
2001 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Accelerator/Inc LATEST DEAL TYPE
3 INVESTORS
Description

Developer of advanced DNA immunotherapies created to target HIV infection. The company's platform GenePro, is a proprietary DNA composition that synthetically mimics the virus in order to generate an immune response that is less toxic than current AIDS drug cocktails, enabling doctors to reduce infections particularly HIV.

Website
Formerly Known As
ImmunoGenetix Therapeutics
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 4220 Shawnee Mission Parkway
  • Suite B350
  • Fairway, KS 66205
  • United States

+1 (888) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore IGXBio’s full profile, request a free trial.

IGXBio Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Accelerator/Incubator 01-Aug-2016 000.00 Completed Startup
4. Early Stage VC 0000 000.00 Completed Startup
3. Grant 01-Jan-2012 00000 Completed Startup
2. Accelerator/Incubator $350K Completed Startup
1. Angel (individual) 16-Feb-2006 $350K $350K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

IGXBio Competitors (35)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
DNAtrix Venture Capital-Backed Houston, TX 00 000.00 00000000000 000.00
000000 Venture Capital-Backed Lebanon, NH 000 000.00 00000000000 000.00
00000000 000000000 Formerly VC-backed Bedford, MA 000 00000 00000000 00000
00000000 Venture Capital-Backed Tübingen, Germany 00 00000 00000000000 00000
000000000 Formerly VC-backed Culver City, CA 000 00000 00000000000 00000
To view this company’s complete list of competitors, request access »

IGXBio Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
JLABS Accelerator/Incubator 000 0000 000000 0
Kansas Bioscience Authority Government 000 0000 000000 0
Enterprise Center of Johnson County Not-For-Profit Venture Capital 000 0000 000000 0

IGXBio Executive Team (2)

Name Title Board
Seat
Contact
Info
James Laufenberg Executive Chairman
David Foster Ph.D President, Chief Executive Officer & Board Member

IGXBio Board Members (6)

Name Representing Role Since Contact
Info
David Foster Ph.D Self President, Chief Executive Officer & Board Member 000 0000
David Tousley Self Board Member 000 0000
Edward Connolly Jr. Self Board Member 000 0000
Edward Stratemeier JD Self Board Member 000 0000
James Laufenberg IGXBio Executive Chairman 000 0000
You’re viewing 5 of 6 board members. Get the full list »